
Home » OPTOS' INVESTORS EYE BIG PROFITS AS FIRM PREPARES FOR £150M
OPTOS' INVESTORS EYE BIG PROFITS AS FIRM PREPARES FOR £150M
OPTOS, the medical equipment company, will float on London's main market next
month valued at an estimated £150m, creating an instant windfall for investors.
The Dunfermline company, run by chief executive Stephane Sallmard, plans to raise
£30m to expand into new overseas markets. A further £20m will be sold
by investors in the company through the institutional placing arranged by Goldman
Sachs.
Scotland
on Sunday
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
28Sep
-
28Sep
-
11Oct
-
16Oct
-
26Oct
-
08Nov